{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:45:28Z","timestamp":1791848728865,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clinsp.2022.100135","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T13:14:47Z","timestamp":1679663687000},"page":"100135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Expression changes and clinical significance of serum neuron-specific enolase and squamous cell carcinoma antigen in lung cancer patients after radiotherapy"],"prefix":"10.1016","volume":"78","author":[{"given":"Lulu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8198-474X","authenticated-orcid":false,"given":"Qing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinsp.2022.100135_bib0001","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ijc.33578","article-title":"Personalising lung cancer screening: An overview of risk-stratification opportunities and challenges","volume":"149","author":"Ten Haaf","year":"2021","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.clinsp.2022.100135_bib0002","article-title":"Progress and prospects of early detection in lung cancer","volume":"7","author":"Blandin","year":"2017","journal-title":"Open Biol"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100135_bib0003","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N","article-title":"Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis","volume":"76","author":"Marino","year":"2015","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.clinsp.2022.100135_bib0004","doi-asserted-by":"crossref","first-page":"e21666","DOI":"10.1200\/JCO.2020.38.15_suppl.e21666","article-title":"The efficacy and safety of EGFR-TKI combined with chemotherapy in Non-Small Cell Lung Cancer (NSCLC) patients with EGFR co-mutation with other oncogenic alterations","volume":"38","author":"Yu","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clinsp.2022.100135_bib0005","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192732","article-title":"Multifunctional neuron-specific enolase: its role in lung diseases","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci Rep"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100135_bib0006","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1245\/s10434-020-08716-y","article-title":"Clinical Significance of pretherapeutic serum squamous cell carcinoma antigen level in patients with neoadjuvant chemotherapy for esophageal squamous cell carcinoma","volume":"28","author":"Okamura","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100135_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100755","article-title":"Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer","volume":"45","author":"Li","year":"2021","journal-title":"Curr Probl Cancer"},{"issue":"15","key":"10.1016\/j.clinsp.2022.100135_bib0008","article-title":"The prognostic biomarkers of the patients treated with platinum-based chemotherapy in treatment emergent or related neuroendocrine prostate cancer","volume":"38","author":"Kosaka","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100135_bib0009","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1002\/ctm2.367","article-title":"The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100135_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13277-014-2623-4","article-title":"A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer","volume":"36","author":"Zhou","year":"2015","journal-title":"Tumor Biol"},{"issue":"3","key":"10.1016\/j.clinsp.2022.100135_bib0011","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jtho.2018.11.023","article-title":"Biomarkers in lung cancer screening: achievements, promises, and challenges","volume":"14","author":"Seijo","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clinsp.2022.100135_bib0012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2019.05.033","article-title":"Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1\/PD-L1 inhibitor treated advanced NSCLC \u2012 a retrospective cohort study","volume":"134","author":"Lang","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clinsp.2022.100135_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8850873","article-title":"The combination of CA125 and NSE is useful for predicting liver metastasis of lung cancer","volume":"2020","author":"Wang","year":"2020","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100135_bib0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.27130","article-title":"Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer","volume":"120","author":"Bai","year":"2019","journal-title":"J Cell Biochem"},{"issue":"33","key":"10.1016\/j.clinsp.2022.100135_bib0015","doi-asserted-by":"crossref","first-page":"e26960","DOI":"10.1097\/MD.0000000000026960","article-title":"Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma","volume":"100","author":"Zhu","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.clinsp.2022.100135_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2082840","article-title":"Identifying the best marker combination in CEA, CA125, CY211, NSE, and SCC for lung cancer screening by combining ROC Curve and logistic regression analyses: is it feasible?","volume":"2018","author":"Yang","year":"2018","journal-title":"Dis Markers"},{"issue":"3","key":"10.1016\/j.clinsp.2022.100135_bib0017","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s13277-015-4034-6","article-title":"Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer","volume":"37","author":"Cho","year":"2016","journal-title":"Tumor Biol"},{"issue":"9","key":"10.1016\/j.clinsp.2022.100135_bib0018","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/1097-0142(19940501)73:9<2305::AID-CNCR2820730911>3.0.CO;2-D","article-title":"Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer","volume":"73","author":"Picardo","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.clinsp.2022.100135_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317714194","article-title":"Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer","volume":"39","author":"Zhou","year":"2017","journal-title":"Tumor Biol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T01:31:32Z","timestamp":1725067892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222033361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":19,"alternative-id":["S1807593222033361"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100135","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression changes and clinical significance of serum neuron-specific enolase and squamous cell carcinoma antigen in lung cancer patients after radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100135"}}